Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01189110 · ClinicalTrials.gov registry record · NA
Auriculotherapy for Smoking Cessation: Pilot
A NA study of Smoking Cessation, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT01189110: Completed NA study of Smoking Cessation, sponsored by US Department of Veterans Affairs.
NCT01189110 is a NA study of Smoking Cessation that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 125 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01189110, a NA study of Smoking Cessation, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
Thirty three percent of our veterans currently smoke. Encouraging smoking cessation continues to be a top priority for the Veteran's Administration as smoking is the single most important preventable risk factor for mortality and morbidity. This study attempts to determine whether auriculotherapy may be used as an effective alternative to usual pharmacological interventions currently offered. Identifying an efficacious alternative method to nicotine patch or bupropion would be highly beneficial to veterans who want to quit smoking. This clinical trial took place at the Veterans Administration Medical Center, in conjunction with the smoking cessation clinic. One hundred twenty five veterans, male and female, age 19 or older, who smoked a minimum of 10 cigarettes per day, were evaluated for enrollment and randomized to two groups- true auriculotherapy and sham auriculotherapy in this 6 week trial.
Primary Outcome
Percentage of study participants free from smoking at 6 weeks based on self-report (yes/no).
Conditions Studied
Interventions
- DEVICE Auriculotherapy using TENS unit Stim Flex 400A
Study Locations (1)
Missouri
- St. Louis VA Medical Center John Cochran Division, St. Louis, MO - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2010-08 |
| Est. Completion | 2011-06 |
| Phase | NA |
What the finished NCT01189110 record still lists
NCT01189110 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which Auriculotherapy using TENS unit Stim Flex 400A is the first listed.
NCT01189110 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT01189110 about?
NCT01189110 is a clinical study titled "Auriculotherapy for Smoking Cessation: Pilot". Thirty three percent of our veterans currently smoke. Encouraging smoking cessation continues to be a top priority for the Veteran's Administration as smoking is the single most important preventable risk factor for mortality and morbidity. This study attempts to determine whether auriculotherapy ma...
What is the current status of trial NCT01189110?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2010-08. Estimated completion is 2011-06.
What conditions does trial NCT01189110 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT01189110?
The interventions under investigation include: Auriculotherapy using TENS unit Stim Flex 400A (DEVICE).
Who is sponsoring clinical trial NCT01189110?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01189110 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01189110's enrollment target sits among peer trials
125 108th of 188 higher than 81 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia